Oxidized low density lipoproteins (oxLDL) are thought to play a major role in atherosclerosis. OxLDL exhibit a wide variety of biological effects resulting from their ability to interfere with intracellular signaling. The cellular targets and primary signaling events of oxLDL are unknown. We report that oxLDL elicit, in intact cells, tyrosine phosphorylation of the epithelial growth factor receptor (EGFR) and activation of its signaling pathway. This activation triggered by oxLDL was associated with derivatization of reactive amino groups of EGFR and was mimicked by 4-hydroxynonenal (4-HNE, a major lipid peroxidation product of oxLDL). Immunopurified EGFR was derivatized and activated in vitro by oxLDL lipid extracts and 4-HNE, thus indicating that 1) EGFR may be a primary target of oxidized lipids and 2) EGFR derivatization may be associated with activation. The reported data suggest that EGFR acts as a sensor for oxidized lipids. We therefore propose a novel concept of the mechanism by which oxidized lipids (contained in oxLDL or more generally produced during oxidative stress) are able to activate receptor tyrosine kinase and subsequent signaling pathways, resulting finally in a gain of function.-Suc, I., Meilhac, O., Lajoie-Mazenc, I., Vandaele, J., Jürgens, G., Salvayre, R., Nègre-Salvayre, A. Activation of EGF receptor by oxidized LDL. FASEB J. 12, 665-671 (1998) 
LOW DENSITY LIPOPROTEINS (LDL)
2 play a major physiological role in delivering cholesterol to peripheral cells and are involved in the genesis of atherosclerosis and subsequent cardiovascular diseases that constitute the most prevalent cause of mortality in Western countries (1) . Oxidized LDL (oxLDL) are present in the arterial wall (2) and are thought to play a central role in atherogenesis (3) . LDL oxidation is a progressive process leading to the formation of mildly oxidized LDL (defined by low content of lipid peroxidation derivatives) and, later, to extensively oxidized LDL (characterized by high levels of lipid peroxidation derivatives and severe apoB alterations) (4) . OxLDL exhibit a wide variety of biological effects potentially involved in atherogenesis, such as alterations of 1) lipid metabolism (leading to foam cell formation), 2) gene expression (of adhesion molecules, heat shock proteins, cytokines, growth factors, coagulation proteins), 3) cell migration, motility, and contractility, 4) cell viability, 5) local immune response, and 6) vasomotor tone (4) (5) (6) .
The biological responses triggered by oxLDL are associated with lipid peroxidation derivatives (reviewed in ref 7) . These bioactive molecules carried by oxLDL may be regarded as 'cellular saboteurs' (7) because they are able to induce various pathogenic intracellular signals leading to cellular dysfunction. OxLDL have been shown to interfere with various signaling pathways involving calcium (8) , trimeric Gproteins and cAMP (9) , phospholipase D (10), protein kinase C (11), ceramide (12) , and MAP kinase cascade (13) . To date, the primary molecular targets and the mechanisms of their activation by oxidized lipids remain largely unknown.
We investigated the possibility that oxLDL may trigger directly intracellular signaling in cultured vascular cells. Preliminary experiments in our laboratory have shown that oxLDL induced early tyrosine phosphorylation of proteins and activation of membranebound tyrosine kinases. One of the tyrosine-phosphorylated proteins was a 170 kDa membrane-bound protein, possibly the epithelial growth factor receptor (EGFR) (14) (15) (16) (17) .
The EGFR is a transmembrane receptor tyrosine kinase shared by several growth factors such as EGF, heparin binding EGF (HB-EGF), TGF-a, amphiregulin, and betacellulin. EGFR is implicated in various biological processes such as cell proliferation or differentiation, and may be involved in the genesis or progression of atherosclerosis and a number of human malignancies.
EGFR activation is associated with the stimulation of its intrinsic tyrosine kinase, with autophosphorylation of its own tyrosine residues, and with phosphorylation of intracellular substrate proteins. Phosphotyrosines of the COOH-terminal domain of the EGFR may bind to SH2 domains of enzymatic or adaptor proteins, including phospholipase C-g1 (18), GTPase-activating protein of p21ras (18, 19) , syp phosphotyrosine phosphatase (or SH2-containing phosphotyrosine phosphatase: SH-PTP1D) (20, 21) , p85 subunit of phosphatidylinositol 3-kinase (PI3K) (22, 23) , shc (24), Grb2-Sos (25) , and nck (26) (27) (28) .
We report that oxLDL elicit, in intact cells, tyrosine phosphorylation and activation of the EGFR. EGFR activation by oxLDL was associated with derivatization of reactive amino groups of EGFR and was mimicked by lipid extracts from oxLDL and by 4-hydroxynonenal (4-HNE, a major lipid peroxidation product). Immunopurified EGFR was derivatized and activated in vitro by oxLDL lipid extracts and 4-HNE, thus indicating that 1) EGFR may be a primary target of oxidized lipids, and 2) EGFR activation may result from derivatization by 4-HNE. These reported data suggest that EGFR acts as a sensor for oxidized lipids and led us to propose a novel concept about the mechanism of activation of signaling pathways (gain of function) by oxidized lipids.
MATERIALS and METHODS

Chemicals
[g-33 P]ATP was from ICN Biomedicals (Orsay, France), 4-HNE was from Tebu-Biomol (Le Perray en Yvelines, France), anti-EGFR antibodies were from Santa Cruz (Tebu, Le Perray-en-Yvelines, France), anti-phosphotyrosine protein antibody (anti-PTyr 4-G10, UBI) was from UBI (Euromedex, Souffelweyersheim, France), RPMI-1640 (containing Glutamax), penicillin, streptomycin, and fetal calf serum were from Gibco (Cergy-Pontoise, France), and acrylamide-41/bisacrylamide-21 solution was from Bioprobe (Montreuil, France); other chemicals were from Merck (Darmstadt, Germany), Sigma (St. Louis, Mo.), or Prolabo (Paris, France).
Cell culture
The human endothelial cell line (CRL-1998 EC) was from American Type Culture Collection (Rockville, Md.) and bovine aortic smooth muscle cells (GM 08133A) were from the NIA Aging Cell Repository (Camden, N.J.). Cells were routinely grown in RPMI 1640 medium (Life TechnologiesGibco) containing 10% fetal calf serum (Biowhittaker, Gagny, France) and antibiotics, as described (29) . All passages were made at a splicing ratio of 1:4. Twenty-four hours before LDL or 4-HNE incorporation, the standard medium was changed and replaced by a serum-free medium.
LDL isolation and oxidation
LDL from human pooled sera were isolated by sequential centrifugation and oxidized by two different methods: UV-C irradiation in the presence of 5 mM CuSO4 or cell-mediated oxidation (one night of incubation with nonconfluent CRL-1998 EC, as described in ref 29) . The level of LDL oxidation was monitored by the formation of thiobarbituric reactive substances (TBARS), according to Yagi (30) . The 4-HNE content of LDL was determined by high-performance liquid chromatography (HPLC), under the conditions of Esterbauer et al. (31) . Briefly, 2 mg of native or oxLDL was extracted by the Folch procedure in the presence or absence of 1 mg of pure 4-HNE (Biomol-TEBU) as internal standard. Lipid extracts were dissolved in acetonitrile and analyzed by HPLC, using a Beckman Gold System equipped with a C18 column (250 1 4.6 mm from Bischoff Chromatography; elution with acetonitrile/water 50:50, v/v, 1 ml/min; detection at 220 nm). Under standard conditions, oxLDL used here contained 4-6 nmol TBARS, 6-10 nmol 4-HNE/mg apoB, and no major alteration of the apoB moiety (29) .
Immunoprecipitation and Western blot analysis
After stimulation of subconfluent CRL 1998-EC monolayers by oxLDL or 4-HNE under the conditions indicated in the text, cells were washed in phosphate-buffered saline (PBS) containing 20 mM sodium fluoride, 20 mM sodium pyrophosphate, 1 mM orthovanadate, and 5 mM EDTA. Cells were then lysed with solubilizing buffer (50 mM Tris pH 7.4, 250 mM NaCl, 5 mM EDTA, 1 mM sodium vanadate, 10 mM sodium pyrophosphate, 160 mM sodium fluoride, 2.5 mM phenylmethylsulfonyl fluoride, 10 mM leupeptin, 2 mM pepstatin A, 10 mg/ml aprotinin, 1% triton X-100) for 30 min, on ice. Fifty micrograms of protein cell extracts (determined by the bicinchoninic acid method) were resolved by electrophoresis in a 7.5% sodium dodecyl sulfate (SDS)-polyacrylamide gel, transferred onto nitrocellulose membrane (Hybond-C, Amersham), and probed with anti-PTyr or anti-EGFR antibodies. Bound proteins were detected by an ECL detection system (Amersham), using a peroxidase-coupled secondary antibody. EGFR was immunoprecipitated by incubating cell extracts (2-4 mg cell protein) with anti-EGFR overnight at 4ЊC. Anti-EGFR immunoprecipitates were recovered on protein G-sepharose (2 h incubation at 4ЊC), eluted by boiling in SDS-containing buffer, and analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting, as indicated above (32, 33) .
Derivatization of EGFR-free amino groups
The free amino group content was evaluated on EGFR immunoprecipitates obtained from CRL 1998-EC previously incubated without (control) and with EGF (10 nM for 20 min), native or oxLDL (200 mg apoB/ml for 3 h), or with pure 4-HNE (Biomol Res. Lab.) (100 nM for 3 h). Free amino groups were labeled with [ (34) . The immunoprecipitates were washed three times in borate buffer, boiled in SDS-containing buffer, and EGFRs were resolved by SDS-PAGE. The 170 kDa bands were recovered and the radioactivity was determined by liquid scintillation counting.
Alternatively, EGFR was immunoprecipitated from unstimulated CRL 1998-EC and incubated for 10 min without (control) or with EGF, lipid extracts from native or oxLDL, or pure 4-HNE. After washing in borate buffer, the immunoprecipitates were labeled by [ (29) . f ) Coimmunoprecipitation of EGFR with associated SH2 proteins in CRL-1998 EC pulsed with oxLDL for 1, 3, and 5 h. EGFR immunoprecipitates were probed with antiphosphotyrosine and anti-phospholipase Cg, an anti-PI-3 kinase 85 kDa subunit, and anti-SH-PTP2 antibodies.
EGFR autophosphorylation and tyrosine kinase activity
EGFR was immunoprecipitated from CRL-1998 EC that was either unstimulated or preincubated with the different agents EGF, 4-HNE, and native or oxLDL lipid extracts (37ЊC, 15 min). EGFR autophosphorylation was evaluated by incubating the immunoprecipitates with 20 mM ATP containing 5 mCi of [g-33 P]ATP (3000 Ci/mmol, Isotopchim) in phosphorylation buffer (50 mM Hepes pH 7.5, 150 mM NaCl, 10 mM MnCl 2 , 10 mM MgCl 2 , 10 mM NaVO 4 , 0.2 % Triton X-100). After incubation (15 min at 37ЊC), the reaction was stopped by spotting an aliquot of the mixture on phosphocellulose membranes (Life Technologies) and the radioactivity was counted (32) . EGFR tyrosine kinase activity was evaluated under the same conditions by phosphorylation of poly Glu-Tyr (33) .
Binding experiments
The ability of oxLDL to compete with the binding and uptake of [
125 I]EGF to CRL 1998-EC was determined according to Marikovsky et al. (36) . Briefly, CRL 1998-EC (plated in 6-multiwell culture plates) were incubated with tracer amounts of [ 125 I]EGF (70.000 cpm/ml) (NEN) alone or in the presence of 200 mg/ml oxLDL, up to 60 min. After washing the cells twice in PBS containing 0.5% bovine serum albumin and once in PBS alone, the cell-associated radioactivity was counted (Minaxi gamma Packard Counter).
RESULTS
Oxidized LDL induce tyrosine phosphorylation of EGFR in cultured cells
Incubation of AG-08133A smooth muscle cells with oxLDL (200 mg apoB/ml) elicited a relatively early tyrosine phosphorylation of cell proteins. As shown in Fig. 1a , a 170 kDa protein labeled in response to oxLDL was intensely tyrosine phosphorylated in response to EGF, thus suggesting a possible identity with the EGFR. The identity of this 170 kDa protein (EGFR) was confirmed by immunoprecipitation and Western blot analysis (Fig. 1) . Tyrosine phosphorylation of EGFR, induced by oxLDL, was time and dose dependent (Fig. 1b-d) . The EGFR tyrosine phosphorylation induced by oxLDL was sustained for several hours (Fig. 1b) . EGFR tyrosine phosphorylation was also dependent on oxLDL concentration in the culture medium, the maximal phosphorylation being observed with oxLDL concentrations higher than 100 mg apoB/ ml (Fig. 1d) . We further examined whether EGFR tyrosine phosphorylation was dependent on the conditions of LDL oxidation. As shown in Fig. 1e , cell oxLDL were also able to induce EGFR tyrosine phosphorylation. In contrast, native (i.e., nonoxidized) LDL either were not active or were only poorly active.
Effective EGFR activation is associated with autophosphorylation and specific interaction with SH2-containing proteins such as phospholipase Cg1, SH-PTP2/syp, PI3K, GRB-2, and SHC, thereby inducing the signaling cascade of EGFR. We therefore investigated whether oxLDL-dependent phosphorylation of EGFR was also able to induce the recruitment and activation of such specific SH2-containing proteins. As shown by Fig. 1f , in CRL-1998 EC treated with oxLDL, EGFR coimmunoprecipitated with at least three target tyrosine-phosphorylated proteins: SH-PTP2/syp (69 kDa), PI-3 kinase p85 subunit (85 kDa), and phospholipase Cg (145 kDa). Moreover, concomitant with phospholipase Cg phosphorylation, PtdIns were hydrolyzed, as assessed by inositolphosphate and diacylglycerol release (data not shown). All these data strongly suggest that oxLDL are able to trigger sustained EGFR phosphorylation as well as activation of the downstream signaling pathway (15) (16) (17) .
Phosphorylation of EGFR triggered by oxLDL is independent of any autocrine effect
As oxLDL have been shown to modulate gene expression of growth factors of the EGF familynamely, HB-EGF (37, 38)-we examined the possibility that oxLDL-induced EGFR tyrosine phosphorylation (observed under the experimental conditions used here) may result from an autocrine secretion of EGF, HB-EGF, or other members of the EGF family. Addition of a neutralizing anti-EGF antibody to the culture medium simultaneously with oxLDL did not inhibit the EGFR tyrosine phosphorylation triggered by oxLDL, whereas this neutralizing anti-EGF antibody was effective in inhibiting EGFR tyrosine phosphorylation triggered by EGF (Fig. 2a) . To investigate whether any EGF-like or other autocrine mediator may be involved in this EGFR tyrosine phosphorylation, the effect of a preconditioned medium was tested on reporter cells. CRL-1998 EC were 'pulsed' for 1, 3, and 5 h with oxidized LDL (200 mg apoB/ml), and after washing were 'chased' for 1 h in oxLDL-free basic medium. This preconditioned chase medium was then transferred to unstimulated 'reporter' CRL-1998 EC. Under these experimental conditions, the preconditioned medium induced no significant tyrosine phosphorylation of EGFR (Fig.  2b) , which suggests that, in our experimental model system, EGFR tyrosine phosphorylation is probably independent of any autocrine mediator.
Finally, to examine the possibility that oxLDL may be associated with any EGF-like activity or may bind the EGFR, binding of radiolabeled [ lation is probably independent of any EGF-like activity associated with oxLDL.
OxLDL and 4-HNE induce derivatization of EGFRfree amino groups
The biological activity of oxLDL is associated mainly with their content in lipid peroxidation products (7), some being highly reactive compounds able to bind and modify cellular proteins. For instance, 4-HNE, one of the major aldehydes formed during LDL oxidation, is able to react with primary amines of basic amino acids and with histidine, thus generating HNE protein adducts (39, 40) . We hypothesized that similar derivatization of basic amino acids of EGFR by 4-HNE may occur during treatment of cells with oxLDL. The content of free reactive amino groups (determined using [ 3 H]succinimidyl propionate, an amine reactive probe) has been evaluated on EGFR immunoprecipitates from intact CRL-1998 EC treated with EGF, native LDL, oxLDL, or 4-HNE. The EGFR-free reactive amino group content was significantly reduced in cells treated with oxLDL or 4-HNE, but not in cells treated with EGF and native LDL (Fig. 3A) . This led us to investigate whether lipid peroxidation products and 4-HNE were able to react directly with EGFR. In vitro incubation of EGFR (purified by immunoprecipitation) with lipid extracts from oxLDL or 4-HNE resulted in a decrease of the free reactive amino group content of EGFR, in contrast to EGF and native LDL (Fig. 3B) . These data strongly suggest that lipid peroxidation compounds contained in oxLDL are able to derivatize free reactive amino groups of EGFR in intact cells. This assumption was supported by direct detection of 4-HNE adducts on a Western blot of the immunoprecipitated EGFR by an anti-4-HNE protein antibody (Fig. 3C ).
4-HNE is able to trigger EGFR phosphorylation and activation
We further investigated whether 4-HNE, in addition to the formation of EGFR adducts, was able to induce EGFR tyrosine phosphorylation similarly to oxLDL. Incubation of intact CRL-1998 EC with 4-HNE (100 nM) induced a time-dependent EGFR tyrosine phosphorylation (Fig. 4a) . More strikingly, as shown by Western blotting (Fig. 4b) , in vitro incubation of immunoprecipitated EGFR with oxLDL lipid extract or 4-HNE induced a significant EGFR tyrosine phosphorylation (similar to that induced by EGF). Similarly, lipid extracts from oxLDL or 4-HNE induced both in vitro EGFR autophosphorylation (as shown by 33 P incorporation, Fig. 4c ) and stimulation of the activity of the EGFR tyrosine kinase (Fig. 4d) . These data strongly suggest that derivatization of reactive amino groups of EGFR by 4-HNE was associated with activation of the intrinsic tyrosine kinase activity of EGFR and subsequent EGFR tyrosine phosphorylation.
DISCUSSION
Collectively, our results indicate that oxLDL induce EGFR tyrosine phosphorylation and effective activation of the EGFR signaling pathway, as shown by the association of SH2-containing proteins to tyrosinephosphorylated EGFR. EGFR activation began at nontoxic concentrations of oxLDL (50 and 100 mg apoB/ml) or 4-HNE (10 and 100 nM). Activation of the EGFR signaling pathway may be involved in a broad range of biological effects of oxLDL.
The novelty of our results lies in the identification of 1) EGFR as a primary target of oxidized lipids, 2) a new mechanism of EGFR activation by lipid peroxidation products, and 3) 4-HNE as a possible mediator of EGFR activation. EGFR activation was autophosphorylation (b, c) and tyrosine kinase activation (d) of EGFR induced by EGF, 4-HNE, and oxLDL lipid extracts. EGFR purified by immunoprecipitation from unstimulated CRL-1998 EC was incubated for 10 min without (control) or with EGF (10 nM), with lipid extracts from native LDL or oxLDL (containing 0.6 and 9 nM 4-HNE, respectively), or with pure 4-HNE (10 and 100 nM). b) EGFR tyrosine phosphorylation was performed for 15 min in phosphorylation buffer as indicated in Methods. Then, SDS-PAGE and immunoblots were performed as described above. c) Same experiments as in panel b, in the presence of 5 mCi/ assay of [g- 33 P]ATP (3000 Ci/mmol, Isotopchim). After spotting on phosphocellulose membranes, the radioactivity was counted. d) EGFR tyrosine kinase activity was evaluated under the same conditions, but in the presence of poly Glu-Tyr. associated with derivatization of EGFR amino groups in intact living cells as well as in vitro. This is consistent with previous reports demonstrating that oxidized lipids, particularly 4-HNE, are able to react with amino groups of lysine and histidine and with sulfhydryl groups of proteins or peptides, leading to the generation of stable HNE protein adducts with cellular proteins during oxidative stress (39, 40) .
Various nonspecific factors, such as Salmonella (41), UV-C radiation (42) (43) (44) , and H 2 O 2 (45) are able to induce EGFR autophosphorylation independent of EGF binding. But EGFR autophosphorylation induced by UV-C is a transient event (42) , whereas that induced by oxidized lipids is sustained for several hours, thus suggesting that different mechanisms probably are involved. H 2 O 2 and UV radiations, via generation of reactive oxygen species (44), act presumably through the inhibition of phosphotyrosine phosphatases (PTPases), which in turn may enhance EGFR phosphorylation. In vitro experiments using immunopurified EGFR suggest a direct mechanism involving derivatization of EGFR by oxidized lipids and subsequent autophosphorylation and activation of the receptor (in these experiments, PTPases were not involved because they were inhibited by NaVO 4 in assays as well as in controls). In intact cells, however, it is not excluded that oxidized lipids may inhibit PTPases, thereby enhancing EGFR autophosphorylation in addition to the direct activation subsequent to derivatization.
The reported data support several relatively new concepts: 1) oxLDL act as local autoparacrine mediators (formed mainly in the vascular wall and acting on neighboring cells); 2) EGFR is a novel cellular target of oxLDL in addition to those previously reported (8-13), but to our knowledge this is the first primary target identified to date; 3) derivatization of EGFR by oxidized lipids elicits directly EGFR activation (i.e., is associated with a gain of function) in contrast to the general concept that protein modification by lipid peroxidation products results generally in a loss of function and cytotoxicity (39) (40) ; and 4) oxidized lipids and 4-HNE therefore share several properties with signaling mediators, since they are short-lived (31), effective activators of signaling pathways and are active at low concentrations.
Finally, the poor specificity of protein derivatization by oxidized lipids allows us to predict that they may alter the function of various intracellular effectors and induce a broad spectrum of biological effects.
